TAG:
cap
Why Wall Street Likes Histology Lab Business
CEO SUMMARY: Over the past two decades, investor-owned anatomic pathology companies captured significant market share from community hospital-based pathology groups while delivering profits to their owners. Despite the recent downturn in the economy, Wall Street believes histolog…
April 27, 2009 “Intelligence: Late Breaking Lab News”
As unemployment rates climb in the United States, employers are ordering fewer pre-employment drugs of abuse (DOA) screening panels. This is expected. It is why investors know that drugs-of-abuse volumes are closely linked to the economic boom/bust cycle. During first quarter earning calls, public la…
Warning: Three-Fold Rise In EMR Adoption Predicted
CEO SUMMARY: Doctors are responding to news that up to $20 billion in federal funding is now available to help pay for their adoption of electronic medical record (EMR) systems. Demand for EMRs is expected to increase three-fold in the coming years. That means clinical labs and p…
Inverness Medical, ACON, LabInfotech, Kaiser Permenante
INVERNESS ACQUIRES TEST BUSINESS FROM ACON WITH A STRATEGY OF BECOMING DOMINANT in the consumer testing market and point-of- care (POC) testing sector, Inverness Medical Innovations, Inc., of Waltham, Massachusetts, has actively acquired companies a…
Hey Doc! How Do You Rate With Zagat Health Survey?
CEO SUMMARY: Once patients become involved in managing their healthcare, they actively seek information that can help them make informed decisions. Health insurers are providing tools to help make this job easier. WellPoint teamed up with Zagat Survey to create …
April 6, 2009 “Intelligence: Late Breaking Lab News”
Effective May, 1, 2009, Laboratory Corporation of America will no longer be a contract provider for Regence BlueShield, head-quartered in Seattle, Washington. Regence notified physicians that it was ending its relationship with LabCorp “as a result of rising co…
Medically Unlikely Edits Are Back–and a Problem!
CEO SUMMARY: On January 1, 2009, CMS implemented Phase VIII of its policy on medically unlikely edits (MUEs) involving about 100 laboratory CPT Codes. It also began to deny whole claims, not just the “medically unlikely” parts of claims. After hearing of the problem in early …
Aperio, Cerner Interface Digital Path and Path LIS
CEO SUMMARY: For pathologists watching the market acceptance of digital imaging and digital pathology systems, another milestone has been reached. The nation’s largest health IT companies are beginning to develop interfaces between their anatomic pathology laboratory informatio…
Boston’s Beth Israel Scores Improvement Gains with Lean
CEO Summary: Lean methods are helping laboratories resolve aggravating problems that have been unresolvable for as long as 10 years. At Beth Israel Deaconess Medical Center in Boston, improvement teams involving the laboratory and ED staff addressed high rates of hemolyzed specim…
Unprecedented Times Lie Ahead For Labs
CEO SUMMARY: Here’s a lab industry first: insight and analysis about why hospital/health system laboratories are already feeling the financial pinch as their parent organizations scramble to conserve and accumulate cash. That’s bad news for IVD vendors and other lab industry …
CURRENT ISSUE
Volume XXXII, No. 12 – August 25, 2025
In an exclusive interview, a laboratory industry M&A specialist discusses what’s driving lab outreach sales to national lab companies. Also, The Dark Report analyzes ways in which pathology and clinical labs can profitably partner with pharmaceutical companies.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.